HCA Healthcare, Inc. $HCA Position Boosted by Vise Technologies Inc.

Vise Technologies Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 17.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,023 shares of the company’s stock after buying an additional 2,690 shares during the period. Vise Technologies Inc.’s holdings in HCA Healthcare were worth $7,691,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. raised its position in shares of HCA Healthcare by 24.7% in the third quarter. SBI Securities Co. Ltd. now owns 111 shares of the company’s stock worth $47,000 after acquiring an additional 22 shares during the period. Beacon Capital Management LLC grew its position in shares of HCA Healthcare by 0.7% during the 3rd quarter. Beacon Capital Management LLC now owns 3,631 shares of the company’s stock valued at $1,550,000 after acquiring an additional 25 shares during the period. Diversify Advisory Services LLC increased its stake in shares of HCA Healthcare by 3.3% in the 3rd quarter. Diversify Advisory Services LLC now owns 806 shares of the company’s stock valued at $378,000 after purchasing an additional 26 shares in the last quarter. AdvisorNet Financial Inc increased its position in shares of HCA Healthcare by 3.5% in the third quarter. AdvisorNet Financial Inc now owns 994 shares of the company’s stock valued at $468,000 after buying an additional 34 shares in the last quarter. Finally, Integrated Advisors Network LLC raised its stake in shares of HCA Healthcare by 0.6% during the 3rd quarter. Integrated Advisors Network LLC now owns 5,469 shares of the company’s stock worth $2,334,000 after buying an additional 35 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 1.1%

HCA stock opened at $467.89 on Tuesday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a market cap of $101.30 billion, a price-to-earnings ratio of 15.50, a price-to-earnings-growth ratio of 1.53 and a beta of 1.10. The business has a fifty day moving average of $438.21 and a two-hundred day moving average of $444.84.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company’s revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.96 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.15 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.34%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $381.00 to $468.00 and gave the stock an “equal weight” rating in a report on Monday. UBS Group dropped their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Finally, Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $479.48.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo raised its price target for HCA from $381 to $468 while maintaining an “equal weight” rating. The higher target reflects improved valuation support, although the rating signals limited expected upside at current levels. Wells Fargo HCA price-target update
• Positive Sentiment: HCA’s price target was also raised to $521 in a separate analyst update, while KeyCorp reportedly strengthened its earnings-per-share estimates. These revisions may support investor confidence in the company’s earnings outlook. HCA price target raised to $521 KeyCorp HCA EPS estimate update
• Neutral Sentiment: An HCA subsidiary is planning a senior-notes offering. The financing could provide capital for operations or investment, but it would also increase debt obligations; terms such as pricing and size will determine the ultimate impact. HCA subsidiary senior-notes offering HCA senior notes offering
• Neutral Sentiment: HCA released renderings for a planned $300 million hospital in Cape Coral, Florida, with tax support. The project points to long-term expansion but may require substantial capital before contributing meaningfully to earnings. HCA Cape Coral hospital project
• Negative Sentiment: A reported HCA data breach affected approximately 55,000 people, creating potential costs related to remediation, regulatory scrutiny and reputational damage. HCA data breach
• Negative Sentiment: Reports warn of payer pressure ahead of HCA’s 2027 outlook. Concerns over reimbursement rates and negotiations could weigh on margins and temper the benefit of stronger earnings estimates. HCA payer pressure outlook

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.